Recent Updates
Recently added Catalysts
OABI Positive Sentiment

OmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst Day

Key Takeaway: OmniAb, Inc. hosted its Investor & Analyst Day in Emeryville, CA, showcasing significant advancements in its partner pipeline and technology platforms. The event featured the introduction of the OmniTides™ peptide discovery platform and updates on the xPloration® platform. These developments indicate OmniAb's commitment to enhancing its therapeutic discovery capabilities.

Market Sentiment Analysis

POSITIVE FACTORS

  • Introduction of the OmniTides™ peptide discovery platform.
  • Highlighting recent partner developments.
  • Broader rollout of the xPloration® platform.

Full Press Release Details

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today hosts its Investor & Analyst Day in Emeryville, CA. With a full presentation agenda, the event highlights recent partner developments, the broader roll out of the xPloration® platform, and introduces the OmniTides™ peptide discovery platform and brand. “We look forward to bringing together our investment com

Frequently Asked Questions

What was highlighted at OmniAb's Investor Day?

OmniAb's Investor Day highlighted recent partner developments and the introduction of the OmniTides™ platform.

What is the OmniTides™ platform?

The OmniTides™ platform is a new peptide discovery platform introduced by OmniAb.

Where was the Investor & Analyst Day held?

The Investor & Analyst Day was held in Emeryville, California.

What is the xPloration® platform?

The xPloration® platform is a technology platform that OmniAb is rolling out more broadly.

Last updated: Oct 6, 2026